Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Keratin 8 pseudogene 40 (KRT8P40) is classified as a processed pseudogene, meaning it is a non-coding genomic sequence related to the functional keratin 8 gene (KRT8), but with inactivating mutations or disruptions that prevent protein expression[4]. KRT8P40 does not encode a functional protein, and there is no evidence it participates in biological processes or disease. The keratin family as a whole consists of intermediate filament proteins essential for the structural stability of epithelial cells, but pseudogenes like KRT8P40 are generally considered evolutionary remnants with no known function[3][4]. KRT8P40 is not included in major biomedical databases (e.g., UniProt, GeneCards) as a therapeutic or functional target and shows no relevance for drug discovery, diagnostics, or biomarker use[1][2][4]. If the intent was to refer to the protein-coding Keratin 8 gene (KRT8), that is a well-characterized structural protein with relevance to cell integrity and marker use in epithelial cancers, but KRT8P40 itself refers specifically to a non-functional pseudogene[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Keratin 8 pseudogene 40 (KRT8P40).